The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
1. Verfasser: | Jackson, M |
---|---|
Weitere Verfasser: | Vallis, K |
Format: | Abschlussarbeit |
Sprache: | English |
Veröffentlicht: |
2013
|
Schlagworte: |
Ähnliche Einträge
-
Selective targeting of homologous recombination deficiency
von: Zimmer, J
Veröffentlicht: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
von: Albukhari, A
Veröffentlicht: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
von: Albukhari, A
Veröffentlicht: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
von: Potter, M
Veröffentlicht: (2014) -
Radiopharmaceutical Validation for Clinical Use
von: Charles A. Kunos, et al.
Veröffentlicht: (2021-03-01)